AI in the clinical management of GA: A novel therapeutic universe requires novel tools

Reiter, Gregor S.; Mai, Julia; Riedl, Sophie; Birner, Klaudia; Frank, Sophie; Bogunovic, Hrvoje; Schmidt-Erfurth, Ursula

doi:10.1016/j.preteyeres.2024.101305

Progress in Retinal and Eye Research

2024

DOI: 10.1016/j.preteyeres.2024.101305

|View full text |Cite

AI in the clinical management of GA: A novel therapeutic universe requires novel tools

Gregor S. Reiter,

Julia Mai,

Sophie Riedl

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 153 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs

Duncan,

Bowman,

Laster

et al. 2024

Trans. Vis. Sci. Tech.

View full text Add to dashboard Cite

Inherited retinal degeneration (IRD) disease and age-related macular degeneration (AMD) are leading causes of irreversible vision loss and blindness. Although significant progress has advanced the field in the past 5 years, significant challenges remain. The current article reviews the accomplishments and research advances that have fueled the development of treatments for patients with IRD and AMD, including the first approved gene-augmentation treatment for RPE65- related retinal degeneration and complement inhibition therapies to slow progression of geographic atrophy (GA) in AMD. The article outlines opportunities to address gaps and unmet needs that should lead to additional progress toward the development of treatments for patients with IRDs and non-neovascular AMD in the future.

show abstract

Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs

Duncan,

Bowman,

Laster

et al. 2024

Trans. Vis. Sci. Tech.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

AI in the clinical management of GA: A novel therapeutic universe requires novel tools

Cited by 1 publication

References 153 publications

Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs

Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs

Contact Info

Product

Resources

About